Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Samsung Bioepis teams with Takeda to take first steps into novel biologics space

Samsung Bioepis says it will continue focusing on biosimilars as it ventures into the innovative biologics space through a partnership with Takeda.


AstraZeneca ups its mRNA stake through €25m Ethris deal

AstraZeneca has entered a five-year collaboration to develop therapies for respiratory diseases based on Ethris’ messenger RNA (mRNA) technology.

VistaGen’s cell production methods receive US patent boost

VistaGen Therapeutics has received a notice of allowance for a stem cell production patent, which the firm says could be used in autoimmune disorder and cancer treatments.

Agilent 'outpacing the market' with double-digit biopharma growth

Agilent Technologies says it is benefitting from increased antibody and biosimilar R&D and manufacturing, reporting a double-digit growth for its third quarter.

Vendors optimistic for future despite slowdown in growth

Bioprocessing suppliers have recently expressed optimism in the sector despite a slowdown in growth, and one expert believes this will drive investment in new tech and markets.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...